Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela… - The Lancet, 2014 - thelancet.com
Summary Background The European Randomised study of Screening for Prostate Cancer
(ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 …
被引用次数：1915 相关文章

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela… - The Lancet, 2014 - lup.lub.lu.se
The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown
significant reductions in prostate cancer mortality after 9 years and 11 years of follow-up, but …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

FH Schroder, J Hugosson, MJ Roobol… - …, 2014 - researchportal.helsinki.fi
Screening and prostate cancer mortality: results of the European Randomised Study of
Screening for Prostate Cancer (ERSPC) at 13 years of follow-up — University of Helsinki Skip to …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

FH Schröder, J Hugosson, MJ Roobol… - Lancet (London …, 2014 - europepmc.org
Background The European Randomised study of Screening for Prostate Cancer (ERSPC)
has shown significant reductions in prostate cancer mortality after 9 years and 11 years of …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

F Schröder, J Hugosson, M Roobol, T Tammela… - The Lancet, 2014 - hal.science
Background: The European Randomised study of Screening for Prostate Cancer (ERSPC)
has shown significant reductions in prostate cancer mortality after 9 years and 11 years of …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

FH Schröder, J Hugosson, MJ Roobol… - Lancet (British …, 2014 - researchportal.vub.be
BACKGROUND: The European Randomised study of Screening for Prostate Cancer
(ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela… - The Lancet, 2014 - infona.pl
The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown
significant reductions in prostate cancer mortality after 9 years and 11 years of follow-up, but …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

FH Schröder, J Hugosson, MJ Roobol… - Lancet (London …, 2014 - folia.unifr.ch
METHODS ERSPC is a multicentre, randomised trial with a predefined centralised
database, analysis plan, and core age group (55-69 years), which assesses prostate …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela… - The Lancet, 2014 - thelancet.com
Summary Background The European Randomised study of Screening for Prostate Cancer
(ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 …

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

FRH Schröder, J Hugosson… - The lancet …, 2014 - repository.uantwerpen.be
Background The European Randomised study of Screening for Prostate Cancer (ERSPC)
has shown significant reductions in prostate cancer mortality after 9 years and 11 years of …